When was Epinostics founded?

Epinostics was founded in 2011.

Where is Epinostics located?

Epinostics is headquartered in London, United Kingdom.

Where does Epinostics rank among its competitors?

Epinostics ranks 485th amongst 513 active competitors, of which 59 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Sebia, which secured an undisclosed amount in May, 2026.

Who are the top competitors of Epinostics?

Epinostics' top competitors include Roche, NVision Imaging Technologies and FOXO Technologies. Among them, Sebia secured the most recent funding round in May, 2026.

Epinostics - 2026 Company Profile & Competitors

Company Details

Developer of non-invasive diagnostic platforms for collecting skin based biomarkers. This technology utilizes skin stretching methods to access and analyze samples for disease detection and health monitoring. It enables the extraction of molecular data without requiring needles or surgical procedures. The platform supports medical applications including precision medicine and systemic health assessment across various demographics.

Key Metrics

Founded Year

2011

Location

London, United Kingdom

Stage

Unfunded

Ranked

485^th among 513 active competitors

Similar Companies

Roche & 364 more

View Epinostics' full profile

Epinostics has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Epinostics include Roche, NVision Imaging Technologies and FOXO Technologies. Here is the list of Top 10 competitors of Epinostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 12 others	71/100
2nd	NVision Imaging Technologies 2015, Ulm (Germany), Series A	Provider of medical imaging by quantum technologies	$35M	Playground Global, Kreissparkasse Esslingen Nurtingen ... & 8 others	63/100
3rd	FOXO Technologies 2020, Minneapolis (United States), Public	Provider of epigenetic diagnostic services alongside rural and behavioral hospitals	$40M	Bespoke Growth Partners, Inc., Centrecourt Asset Management ... Read more	57/100
4th	SonoSite 1986, Bothell (United States), Acquired	Point-of-care ultrasound solutions provider, empowering clinicians with advanced imaging	-	Europa	59/100
5th	Sebia 1967, Evry Courcouronnes (France), Acquired	Developer of electrophoresis-based in vitro diagnostics products	-	Warburg Pincus, HarbourVest Partners & 5 others	58/100
6th	EKF 1990, Penarth (United Kingdom), Public	Develops point-of-care and laboratory blood analyzers	$179K	Octopus Investments, IBG Beteiligungsgesellschaft Sachsen-Anhalt ... & 2 others	56/100
7th	DiaSorin 1968, Saluggia (Italy), Public	Develops and commercializes reagent kits for in vitro diagnostics	-	Eiffel Investment Group, Public Health Emergency ... & 1 others	56/100
8th	Hangzhou Deshi Biotechnology 2016, Hangzhou (China), Public	Devices for HPV virus detection & RNA detection	$30.2M	Xiangjiang Liyuan Investment, Shenzhen Guozhong Venture Capital Management ... & 8 others	56/100
9th	numares 2004, Regensburg (Germany), Series B	Developer of diagnostic tests using metabolomics and nuclear magnetic resonance spectroscopy	$26.8M	Bayern Kapital, Kfw & 2 others	52/100
10th	Sysmex 1968, Kobe (Japan), Public	Developer of diagnostic instruments, reagents, and related software	-	-	55/100
485th	Epinostics 2011, London (United Kingdom), Unfunded	Developer of non-invasive diagnostic platforms for collecting skin based biomarkers	-	-	16/100